Fig. 3From: Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systemsRisk analysis and implementation workflow. Adapted with permission from A Framework for Risk-Based Resource Allocation for Pharmaceutical Quality Assurance for Medicines Regulatory Authorities in Low- and Middle-Income Countries [30]Back to article page